The U.S. Food and Drug Administration (FDA) has approved Benlysta (belimumab) to treat patients with active autoantibody positive lupus (systemic lupus erythematosus) who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives and non steroidal anti-inflammatory drugs.
A recent study published revealed that pay-forperformance programs are effective in incentivizing low-performing physicians.
The number of annual flu deaths ,consistently reported to be 36,000 by the U.S. Centers for Disease Control and Prevention, has been revised.
Prolastin-C has been approved by the Food and Drug Administration for the treatment of alpha1-antitrypsin (AAT)deficiency.
A new study shows that lower levels of serum albumin are associated with greater disease severity in multiple myeloma patients.
Updates on vaccines including herpes, hepatitis E, dengue fever, cervical cancer and more.
Updates on recent FDA approvals, appointments, acquisitions and alliances in the pharmaceutical industry.
The Kaiser Family Foundation has launched an online gateway providing access to new and comprehensive resources on the health reform law.
In August 2010, the Centers for Medicare and Medicaid Services proposed to change the reimbursement rate of separately payable, non-pass-through drugs and biologicals.
Researchers at the University of Oklahoma Health Sciences Center have found a way to create a vaccine using T cells that activate a distinct part of the immune system.
In Massachusetts, a panel of state officials and healthcare executives moved toward global payments by drafting a first-in-the-nation blueprint for scrapping current fee-forservice payments.
U.S. investigators identified and quantitatively combined all available studies evaluating IgG trough levels and pneumonia incidence in PIDD patients receiving IVIG replacement therapy for hypogammaglobulinemia.